Document is current
Any future updates will be listed below
-
Authors
Frediani, Bruno
Gaudio, Agostino
Giannini, Sandro
Lello, Stefano
Napoli, Nicola
Rossini, Maurizio
-
Funding
Funding for this research was provided by:
Theramex
- License Information
-
More Information
Article History
Received: 24 July 2025
Accepted: 15 February 2026
First Online: 28 February 2026
Declarations
:
: Agostino Gaudio reports advisory board honoraria and/or consultancy fees from MSD, UCB Pharma, Theramex Italy, and Sandoz. Maurizio Rossini reports advisory board honoraria, consultancy fees, and/or speaker fees from AbbVie, Eli-Lilly, ItalFarmaco, Janssen Cilag, Neopharmed-Gentili, Theramex, UCB, outside the submitted work. Bruno Frediani, Sandro Giannini, Stefano Lello, and Nicola Napoli declare that they have no conflict of interest related to this study.
